Development and Validation of a Rapid, Simple and Precise LC-MS/MS Method for the Quantification of Vincristine

Priyanka, Vemu; Velraj, Malarkodi

doi:10.48309/ajca.2026.561458.1975

Development and Validation of a Rapid, Simple and Precise LC-MS/MS Method for the Quantification of Vincristine

Document Type : Original Research Article

Authors

Vemu Priyanka ¹

Malarkodi Velraj ²

¹ School of Pharmacy, Vels Institute of Science, Technology & Advanced Studies (VISTAS), Pallavaram, Chennai, 600 117, India

² Department of Pharmacognosy, School of Pharmacy, Vels Institute of Science, Technology & Advanced Studies (VISTAS), Pallavaram, Chennai, 600 117, India

https://doi.org/10.48309/ajca.2026.561458.1975

Abstract

A rapid, precise, and economical LC-MS/MS method was developed and validated for the quantification of vincristine. The method utilizes electrospray ionization in positive mode with multiple reaction monitoring (MRM) for a precursor-to-product ion transition of m/z 825.3 > 807.3. Effective chromatographic separation was achieved using a Thermo Hypurity C18 column (50 mm x 4.6 mm, 5 µm). The mobile phase consisted of 2 mM ammonium formate with 0.2% formic acid in acetonitrile at a ratio of 30:70 (v/v), pumped at a flow rate of 0.5 mL/min. The retention time (RT) for vincristine was 1.21 minutes and the total run time was 2.5 minutes. The method was validated according to ICH Q2(R1) guidelines, with the Limit of Detection (LOD) and Limit of Quantitation (LOQ) determined to be 3 ppm and 10 ppm, respectively, calculated using standard regression statistics. Linearity was established over a concentration range of 10– 150 ppm (y = 698.983 x − 2606.21; R² = 0.995734). Accuracy (mean % recovery) across LOQ, 50%, 100%, and 150% levels was within 91–106%, and precision (relative standard deviation [%RSD]) ranged from 1.2% to 3.1% (intraday and inter-day), meeting the acceptance criteria for routine analysis. The system suitability %RSD for the peak area was 2.27%, and the RSD for RT was 0.45%. The method was successfully applied to quantify vincristine loaded on drug-eluting stents (DES) and to evaluate in vitro release kinetics (DES extraction and release sample testing included in validation). This method is suitable for routine quality control and formulation development of vincristine-containing DES.

Graphical Abstract

Keywords

Vincristine

LC-MS/MS

Validation

ICH Q2(R1)

LOD

LOQ

Subjects

Analytical chemistry

OPEN ACCESS

©2026 The author(s). This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit: http://creativecommons.org/licenses/by/4.0/

PUBLISHER NOTE

Sami Publishing Company remains neutral concerning jurisdictional claims in published maps and institutional affiliations.

CURRENT PUBLISHER

Sami Publishing Company

[1] Shukla, R., Singh, A., Singh, K.K. Vincristine-based nanoformulations: A preclinical and clinical studies overview. Drug Delivery and Translational Research, 2024, 14(1), 1-16.

[2] Silverman, J.A., Deitcher, S.R. Marqibo^®(vincristine sulfate liposome injection) improves the pharmacokinetics and pharmacodynamics of vincristine. Cancer Chemotherapy and Pharmacology, 2013, 71(3), 555-564.

[3] Taub, J.W., Buck, S.A., Xavier, A.C., Edwards, H., Matherly, L.H., Ge, Y. The evolution and history of vinca alkaloids: From the big bang to the treatment of pediatric acute leukemia. Pediatric Blood & Cancer, 2024, 71(11), e31247.

[4] Škubník, J., Pavlíčková, V.S., Ruml, T., Rimpelova, S. Vincristine in combination therapy of cancer: Emerging trends in clinics. Biology, 2021, 10(9), 849.

[5] Lien, L.M., Lu, W.J., Lin, K.H., Kang, L.H., Chen, T.Y., Lin, B.J., Lu, Y.C., Huang, C.Y., Shih, C.M., Chen, H. Influence of vincristine, clinically used in cancer therapy and immune thrombocytopenia, on the function of human platelets. Molecules, 2021, 26(17), 5340.

[6] Guilhaumou, R., Solas, C., Rome, A., Giocanti, M., Andre, N., Lacarelle, B. Validation of an electrospray ionization lc/ms/ms method for quantitative analysis of vincristine in human plasma samples. Journal of Chromatography B, 2010, 878(3-4), 423-427.

[7] Jin, Y., Li, Y., Uddin, M.E., Sparreboom, A., Hu, S. Rapid quantification of vincristine in mouse plasma using esi-lc-ms/ms: Application to pharmacokinetic studies. Journal of Chromatography B, 2021, 1168, 122591.

[8] Kozlik, P., Sirc, J., Cocarta, A.I., Bosakova, Z. A novel highly sensitive uhplc-ms/ms method for monitoring vincristine in plasma and vitreous humor samples with potential application in retinoblastoma therapy. Microchemical Journal, 2022, 178, 107337.

[9] Agu, L., Skiles, J.L., Masters, A.R., Renbarger, J.L., Chow, D.S. Simultaneous quantification of vincristine and its major m1 metabolite from dried blood spot samples of kenyan pediatric cancer patients by uplc-ms/ms. Journal of Pharmaceutical and Biomedical Analysis, 2021, 203, 114143.

[10] Erdogan-Kablan, S., Yayla, S., Hurkul, M.M., Cetinkaya, A., Nemutlu, E., Ozkan, S.A. Recent advancements in the bioactive alkaloids analysis in plant and biological specimen: From the perspective of activity, sample preparation, and analytical method selection. Journal of Chromatography B, 2025, 124592.

[11] van der Heijden, L.T., Uittenboogaard, A., Nijstad, A.L., Gebretensae, A., Kaspers, G.J., Beijnen, J.H., Huitema, A.D., Rosing, H. A sensitive liquid chromatographic-mass spectrometry method for the quantification of vincristine in whole blood collected with volumetric absorptive microsampling. Journal of Pharmaceutical and Biomedical Analysis, 2023, 225, 115232.

[12] Abbasnezhad, N., Zirak, N., Champmartin, S., Shirinbayan, M., Bakir, F. An overview of in vitro drug release methods for drug-eluting stents. Polymers, 2022, 14(13), 2751.

[13] Koopmans, P., Gidding, C.E., de Graaf, S.S., Uges, D.R. An automated method for the bioanalysis of vincristine suitable for therapeutic drug monitoring and pharmacokinetic studies in young children. Therapeutic drug monitoring, 2001, 23(4), 406-409.

[14] Jurowski, K., Paprotny, Ł., Zakrzewski, M., Wianowska, D., Kasprzyk-Pochopień, J., Herman, M., Madej, K., Piekoszewski, W., Kubrak, T. The development of new methodology for determination of vincristine (vcr) in human serum using lc-ms/ms-based method for medical diagnostics. Molecules, 2022, 27(22), 7945.

[15] Qi, P., Li, P., Qiao, L., Xue, H., Ma, Y., Wei, S., Yang, X., Zhang, H., Zhang, Y., Wang, Y. Simultaneous quantification of pirarubicin, doxorubicin, cyclophosphamide, and vincristine in human plasma of patients with non-hodgkin's lymphoma by lc–ms/ms method. Journal of Chromatography B, 2023, 1224, 123754.

[16] Livingston, M., Tan, A. Coating techniques and release kinetics of drug-eluting stents. Journal of Medical Devices, 2016, 10(1), 010801.

[17] Koźlik, M., Harpula, J., Chuchra, P.J., Nowak, M., Wojakowski, W., Gąsior, P. Drug-eluting stents: Technical and clinical progress. Biomimetics, 2023, 8(1), 72.

[18] Judd, E.K., Calhoun, D.A., Warnock, D.G. Pathophysiology and treatment of resistant hypertension: The role of aldosterone and amiloride-sensitive sodium channels. Semin Nephrol, 2014, 34(5), 5329.

[19] Drawz, P., Baumann, D., Dayton, A. Renal denervation: Recent developments in clinical and preclinical research. Current Opinion in Nephrology and Hypertension, 2023, 32(5), 404-411.

[20] Castro Torres, Y., Katholi, R.E. Renal denervation for treating resistant hypertension: Current evidence and future insights from a global perspective. International Journal of Hypertension, 2013, 2013(1), 513214.

[21] Guo, P., Wang, X., Zhou, F., Gallo, J.M. Determination of vincristine in mouse plasma and brain tissues by liquid chromatography–electrospray mass spectrometry. Journal of Chromatography B, 2004, 809(2), 273-278.

[22] Rykowska, I., Nowak, I., Nowak, R. Drug-eluting stents and balloons—materials, structure designs, and coating techniques: A review. Molecules, 2020, 25(20), 4624.

[23] Bian, Y., Gao, C., Kuster, B. On the potential of micro-flow lc-ms/ms in proteomics. Expert Review of Proteomics, 2022, 19(3), 153-164.

[24] Can, N.Ö. Development of validated and stability-indicating lc-dad and lc-ms/ms methods for determination of avanafil in pharmaceutical preparations and identification of a novel degradation product by lcms-it-tof. Molecules, 2018, 23(7), 1771.

[25] Gelb, M.H., Basheeruddin, K., Burlina, A., Chen, H.J., Chien, Y.H., Dizikes, G., Dorley, C., Giugliani, R., Hietala, A., Hong, X. Liquid chromatography–tandem mass spectrometry in newborn screening laboratories. International Journal of Neonatal Screening, 2022, 8(4), 62.

[26] Mercier-Letondal, P., Marton, C., Godet, Y., Galaine, J. Validation of a method evaluating t cell metabolic potential in compliance with ich q2 (r1). Journal of Translational Medicine, 2021, 19(1), 21.

[27] Tyanova, S., Temu, T., Carlson, A., Sinitcyn, P., Mann, M., Cox, J. Visualization of lc‐ms/ms proteomics data in maxquant. Proteomics, 2015, 15(8), 1453-1456.

[28] van der Heijden, L., Gebretensae, A., Thijssen, B., van Andel, L., Nijstad, A., Wang, Y., Rosing, H., Huitema, A., Beijnen, J. A highly sensitive bioanalytical method for the quantification of vinblastine, vincristine, vinorelbine and 4-o-deacetylvinorelbine in human plasma using lc-ms/ms. Journal of Pharmaceutical and Biomedical Analysis, 2022, 215, 114772.

[29] Velagapudi, C., Madassery, S. Drug-eluting stents. Seminars in Interventional Radiology, 2022, 39(04), 400-405.

[30] Yang F, Wang H, Hu P, Jiang J. Validation of an UPLC-MS-MS method for quantitative analysis of vincristine in human urine after intravenous administration of vincristine sulfate liposome injection. J Chromatogr Sci. 2015;53(6):974-978.